Suppression of replicative senescence by rapamycin in rodent embryonic cells
Tatyana V. Pospelova(St Petersburg University), Mikhail V. Blagosklonny(Roswell Park Comprehensive Cancer Center)
Cited by 83
Related Papers
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
|Aging|2010|274
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
|Proceedings of the National Academy of Sciences|2014|153
Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
|American Journal Of Pathology|2012|81
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
|Oncotarget|2015|65
Gerosuppression by pan-mTOR inhibitors
|Aging|2016|65